Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
Amy M. Kilbourne, PhD, MPH: Determinants of Complementary and Alternative Medicine Use by Patients with Bipolar Disorder
1
x
$
30.00
Impact of the Omics-Based Biomarkers on the Fluvoxamine’s Steady-State Concentration, Efficacy and Safety in Patients with Affective Disorders Comorbid with Alcohol Use Disorder
1
x
$
30.00
Carlos A. Zarate, MD: Modulators of the Glutamatergic System: Implications for the Development of Improved Therapeutics in Mood Disorders
1
x
$
30.00
Ahmad Ghanizadeh - Does Risperidone Improve Hyperacusia in Children with Autism?
1
x
$
30.00
Jodi M. Gonzalez, PhD: Treatment Characteristics and Illness Burden Among European Americans, African Americans, and Latinos in the First 2,000 Patients of the Systematic Treatment Enhancement Program for Bipolar Disorder
1
x
$
30.00
Trazodone for Depressed Mood, Anxiety, Insomnia, and Suicidality
1
x
$
30.00
Ramelteon for Insomnia Related to (ADHD) by Rachel E. Fargason
1
x
$
30.00
Can a ‘Shot’ Help Prevent Youth Re-Incarceration? Case Report on Use of a Long-Acting Injectable Antipsychotic in Incarcerated Youth (OPEN ACCESS)
1
x
$
0.00
Donald S. Robinson, MD: Treatment Effects of Selegiline Transdermal System on Symptoms of Major Depressive Disorder: A Meta-Analysis of Short-Term, Placebo-Controlled, Efficacy Trials
1
x
$
30.00
View Cart
Checkout
Home
david-j-goldstein
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Charles B. Nemeroff, MD, PhD: Duloxetine for the Treatment of Major Depressive Disorder
$
30.00
Add to cart
Details
Page load link
Go to Top
